RamiKahwashMD

Heart Failure & Transplantation, Interventional Cardiology

Professor in Internal Medicine Division of Cardiovascular Medicine Section of Heart Failure/Transplant Director of the Heart and Vascular Research Organization The Ohio State University Wexner Medical Center Columbus, Ohio

Join to view full profile

Dr. Kahwash is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kahwash's full profile

Already have an account?

Office
181 Taylor Ave
Fl 13
Columbus, OH 43203
Phone+1 614-688-9337

Fax+1 614-293-2584

Summary

Dr. Rami Kahwash is a cardiologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. He received his medical degree from Damascus University Faculty of Medicine and has been in practice 19 years. He specializes in heart failure & transplantation and interventional cardiology and is experienced in general cardiology, myocarditis, cardiomyopathies, hypertrophic cardiomyopathy, and sarcoidosis-related cardiomyopathy.

Education & Training

Ohio State University HospitalFellowship, Advanced Heart Failure and Transplant Cardiology, 2008 - 2009
University of Kentucky College of MedicineFellowship, Cardiovascular Disease, 2004 - 2007
University of Kentucky College of MedicineResidency, Internal Medicine, 2000 - 2003
Damascus University Faculty of MedicineClass of 1997

Certifications & Licensure

OH State Medical License 2007 - 2026
KY State Medical License 2003 - 2011
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease
International Board of Heart Rhythm Examiners (IBHRE) Certified Cardiac Device Specialist(CCDS)

Awards, Honors, & Recognition

Best doctor
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

REDUCE LAP-HF TRIAL II Start of enrollment: 2017 Jun 01
Active, not recruiting
Not Applicable
REmodeling the Left Ventricle With Atrial Modulated Pacing Start of enrollment: 2017 Sep 15
Completed
Not Applicable
Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy Start of enrollment: 2020 Jan 21
Recruiting
Dietary Supplementation in Heart Failure Start of enrollment: 2019 Apr 01
Completed
Not Applicable
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure Start of enrollment: 2020 Sep 03
Recruiting
Not Applicable
Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2020 Aug 25
Completed
Reveal LINQ™ Heart Failure Start of enrollment: 2016 Jun 08
Completed
Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements Start of enrollment: 2018 Jul 13
Completed
Not Applicable
Reducing Lung CongestIon Symptoms in Advanced Heart Failure Start of enrollment: 2018 Sep 19
Active, not recruiting
Not Applicable
Early Feasibility Study - Transcatheter Atrial Shunt System Start of enrollment: 2018 Jul 31
Recruiting
Not Applicable
Early Feasibility Study of the FIRE1™ System in Heart Failure Patients (FUTURE-HF2) Start of enrollment: 2023 Jun 19
Active, not recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Incidence of atrial fibrillation in patients with an insertable cardiac monitor and symptomatic heart failure.
Muhammad Shahzeb Khan, Michael R Zile, Rami Kahwash, Shantanu Sarkar, Brian Van Dorn
ESC Heart Failure. 2024-12-09
Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation.
Katarzyna Elzbieta Gil, Vien Truong, Chuanfen Liu, Dalia Y Ibrahim, Katarzyna Mikrut
The International Journal of Cardiovascular Imaging. 2024-12-01
Personalized Intervention Strategy Based on a Risk Score Generated From Subcutaneous Insertable Cardiac Monitor: Results From Phase 1 of ALLEVIATE-HF.
Rami Kahwash, Michael R Zile, Prasad Chalasani, Barry Bertolet, Laura Gravelin
Journal of the American Heart Association. 2024-10-15

Journal Articles

Evidence of Aldosterone Synthesis in Human Myocardium in Acute Myocarditis
Rami Kahwash, Subha V Raman, International Journal of Cardiology

Abstracts/Posters

AL Amyloidosis: The Effects of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes
Rami Kahwash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
The Effect of Cytogenetic Abnormalities on Organ Involvement and Survival in Patients with AL Amyloidosis
Rami Kahwash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Safety Data Favor Diuretic Strategy Triggered by Cardiac Monitoring Alerts in HFOctober 11th, 2024
Ohio Heart Center 1st in World to Study Efficacy of Diastolic Heart Failure TreatmentDecember 6th, 2022
Can You Have Sex After a Heart Attack?July 27th, 2022
Join now to see all